2007 AAO News - Ophthalmology Times

ADVERTISEMENT

2007 AAO News

Long-term visual function favorable after optic neuritis

Nov 13, 2007

The final report of the Optic Neuritis Treatment Trial (ONTT) showed that the long-term visual outcome is favorable for patients with unilateral acute optic neuritis even in the presence of multiple sclerosis (MS). The investigators determined that magnetic resonance imaging (MRI) is a valuable prognostic indicator. David Kauffman, DO, from East Lansing, MI, reported the findings on behalf of the Optic Neuritis Study Group at the annual meeting of the American Academy of Ophthalmology.

Functional and microstructural changes in eyes of patients with MS

Nov 13, 2007

Patients with multiple sclerosis (MS) but not optic neuritis may have functional ocular impairments from chronic axonal loss, according to Güngö r Sobaci, MD, from Ankara, Turkey, reporting at the American Academy of Ophthalmology annual meeting.

Fractioned radiotherapy safe and effective for optic nerve sheath meningiomas

Nov 13, 2007

Conformal fractionated radiotherapy should be the first choice of treatment for optic nerve sheath meningiomas, according to Silas Wang, MD.

Transvitreal optic neurotomy improves visual acuity in recent-onset NAION

Nov 13, 2007

Transvitreal optic neurotomy (TON) improves the visual acuity and visual fields in patients with nonarteritic anterior ischemic optic neuropathy (NAION) of recent onset, reported Gholam Peyman, MD, at the American Academy of Ophthalmology annual meeting.

ESCRS postoperative endophthalmitis study results minimally affect U.S. practice patterns so far

Nov 12, 2007

According to the results of an online survey conducted by the ASCRS (American Society of Cataract and Refractive Surgery) Cataract Clinical Committee, the results of the ESCRS (European Society of Cataract and Refractive Surgeons) study of endophthalmitis prophylaxis do not appear to have had a significant impact on the practices of U.S. cataract surgeons, said David F. Chang, MD, at Spotlight on Cataracts 2007.

Non-steroidal anti-inflammatory agent superior to placebo in studies

Nov 12, 2007

Results were presented for two phase III clinical trials of an ocular, non-steroidal anti-inflammatory agent, bromfenac (Xibrom, ISTA Pharmaceuticals). These results were presented by William B. Trattler, MD, at the 2007 annual meeting of the American Academy of Ophthalmology in New Orleans. The new once-daily formulation was evaluated versus placebo in more than 500 patients who underwent cataract surgery.

CCI unrelated to endophthalmitis risk

Nov 12, 2007

Clear corneal incision (CCI) is not a risk factor for post-cataract surgery endophthalmitis, said I. Howard Fine, MD, at Spotlight on Cataracts 2007.

Dr. Claes H. Dohlman, 'founder of modern corneal science,' honored as 2007 Academy Laureate

Nov 12, 2007

The highest honor the American Academy of Ophthalmology can bestow was presented to Claes H. Dohlman, MD, PhD, for his distinguished career and contributions to ophthalmology.

Ten-year follow-up on LASIK for high myopia reported

Nov 12, 2007

Results of 10-year follow-up of patients with high myopia who underwent LASIK indicate that the procedure is safe and effective over the long term, said Juan J. Perez-Santonja, MD, Alicante Institute of Ophthalmology, Miguel Hernandez University, Alicante, Spain. In his study, 40% of eyes avoided use of spectacles, best spectacle-corrected visual acuity (BSCVA) improved 1 line, and complications were infrequent.

ADVERTISEMENT

ADVERTISEMENT

Ophthalmology Times issue
Stay connected to Ophthalmology Times
Receive new issue alerts, technology bulletins, and conference updates!

ADVERTISEMENT

What Do You Think?
Have fireworks caused an eye injury in any of your patients?
Yes
No
View Results
Yes
89%
No
11%
View Results
Click here